Literature DB >> 31952574

Clotting factors: Clinical biochemistry and their roles as plasma enzymes.

William E Winter1, Dina N Greene2, Stacy G Beal1, James A Isom1, Heather Manning3, Gloria Wilkerson3, Neil Harris4.   

Abstract

The purpose of this review is to describe structure and function of the multiple proteins of the coagulation system and their subcomponent domains. Coagulation is the process by which flowing liquid blood plasma is converted to a soft, viscous gel entrapping the cellular components of blood including red cells and platelets and thereby preventing extravasation of blood. This process is triggered by the minimal proteolysis of plasma fibrinogen. This transforms the latter to sticky fibrin monomers which polymerize into a network. The proteolysis of fibrinogen is a function of the trypsin-like enzyme termed thrombin. Thrombin in turn is activated by a cascade of trypsin-like enzymes that we term coagulation factors. In this review we examine the mechanics of the coagulation cascade with a view to the structure-function relationships of the proteins. We also note that two of the factors have no trypsin like protease domain but are essential cofactors or catalysts for the proteases. This review does not discuss the major role of platelets except to highlight their membrane function with respect to the factors. Coagulation testing is a major part of routine diagnostic clinical pathology. Testing is performed on specimens from individuals either with bleeding or with thrombotic disorders and those on anticoagulant medications. We examine the basic in-vitro laboratory coagulation tests and review the literature comparing the in vitro and in vivo processes. In vitro clinical testing typically utilizes plasma specimens and non-physiological or supraphysiological activators. Because the review focuses on coagulation factor structure, a brief overview of the evolutionary origins of the coagulation system is included.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coagulation factors; Enzyme catalysis; Extrinsic and intrinsic pathway; Fibrinogen; Prothrombin; Serine protease; Tissue factor

Mesh:

Substances:

Year:  2019        PMID: 31952574     DOI: 10.1016/bs.acc.2019.07.008

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  5 in total

1.  Nanoporous and nano thickness film-forming bioactive composition for biomedical applications.

Authors:  Naga Thirumalesh Chevala; Lalit Kumar; Vimal Veetilvalappil; Aranjani Jesil Mathew; Bemma Paonam; Ganesh Mohan; Shamee Shastry; Krishnan Balasubramanian; C Mallikarjuna Rao
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

2.  Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment.

Authors:  Krisztina Pénzes; Boglárka Hurják; Éva Katona; Gergely Becs; József Balla; László Muszbek
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

3.  Investigation of the Molecular Mechanism of Coagulopathy in Severe and Critical Patients With COVID-19.

Authors:  Daniel Elieh Ali Komi; Yaghoub Rahimi; Rahim Asghari; Reza Jafari; Javad Rasouli; Mehdi Mohebalizadeh; Ata Abbasi; Rahim Nejadrahim; Farzin Rezazadeh; Vahid Shafiei-Irannejad
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

4.  Novel Inhibitors and Activity-Based Probes Targeting Trypsin-Like Serine Proteases.

Authors:  Timothy E G Ferguson; James A Reihill; S Lorraine Martin; Brian Walker
Journal:  Front Chem       Date:  2022-04-21       Impact factor: 5.545

Review 5.  High Molecular Weight Kininogen: A Review of the Structural Literature.

Authors:  Michał B Ponczek
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.